Minimal hepatic encephalopathy

Charmaine A. Stewart, Glenn E. Smith

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Minimal hepatic encephalopathy (MHE), formerly known as subclinical hepatic encephalopathy, is the mild cognitive impairment commonly seen in patients who have cirrhosis. Current understanding suggests that MHE forms part of the spectrum of hepatic encephalopathy, although this remains to be proven. Although traditionally viewed as having negligible clinical significance, MHE has a significant impact on quality of life. MHE often goes undiagnosed because in many patients there is no evidence of clinically overt signs of impaired cognition. In addition, the diagnostic criteria for MHE have not been standardized, which means that the exact characteristics of MHE remain in question. This Review focuses on the pathogenesis and neuropsychological findings (incorporating neuroimaging) of MHE, as well as the effect of MHE on quality of life and survival, and developments in treatment.

Original languageEnglish (US)
Pages (from-to)677-685
Number of pages9
JournalNature Clinical Practice Gastroenterology and Hepatology
Volume4
Issue number12
DOIs
StatePublished - Dec 2007

Fingerprint

Hepatic Encephalopathy
Quality of Life
Neuroimaging
Cognition
Fibrosis
Survival

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Minimal hepatic encephalopathy. / Stewart, Charmaine A.; Smith, Glenn E.

In: Nature Clinical Practice Gastroenterology and Hepatology, Vol. 4, No. 12, 12.2007, p. 677-685.

Research output: Contribution to journalArticle

Stewart, Charmaine A. ; Smith, Glenn E. / Minimal hepatic encephalopathy. In: Nature Clinical Practice Gastroenterology and Hepatology. 2007 ; Vol. 4, No. 12. pp. 677-685.
@article{8b3478fe90c5475cbc5a6743e0ca29e2,
title = "Minimal hepatic encephalopathy",
abstract = "Minimal hepatic encephalopathy (MHE), formerly known as subclinical hepatic encephalopathy, is the mild cognitive impairment commonly seen in patients who have cirrhosis. Current understanding suggests that MHE forms part of the spectrum of hepatic encephalopathy, although this remains to be proven. Although traditionally viewed as having negligible clinical significance, MHE has a significant impact on quality of life. MHE often goes undiagnosed because in many patients there is no evidence of clinically overt signs of impaired cognition. In addition, the diagnostic criteria for MHE have not been standardized, which means that the exact characteristics of MHE remain in question. This Review focuses on the pathogenesis and neuropsychological findings (incorporating neuroimaging) of MHE, as well as the effect of MHE on quality of life and survival, and developments in treatment.",
author = "Stewart, {Charmaine A.} and Smith, {Glenn E.}",
year = "2007",
month = "12",
doi = "10.1038/ncpgasthep0999",
language = "English (US)",
volume = "4",
pages = "677--685",
journal = "Nature Reviews Gastroenterology and Hepatology",
issn = "1759-5045",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Minimal hepatic encephalopathy

AU - Stewart, Charmaine A.

AU - Smith, Glenn E.

PY - 2007/12

Y1 - 2007/12

N2 - Minimal hepatic encephalopathy (MHE), formerly known as subclinical hepatic encephalopathy, is the mild cognitive impairment commonly seen in patients who have cirrhosis. Current understanding suggests that MHE forms part of the spectrum of hepatic encephalopathy, although this remains to be proven. Although traditionally viewed as having negligible clinical significance, MHE has a significant impact on quality of life. MHE often goes undiagnosed because in many patients there is no evidence of clinically overt signs of impaired cognition. In addition, the diagnostic criteria for MHE have not been standardized, which means that the exact characteristics of MHE remain in question. This Review focuses on the pathogenesis and neuropsychological findings (incorporating neuroimaging) of MHE, as well as the effect of MHE on quality of life and survival, and developments in treatment.

AB - Minimal hepatic encephalopathy (MHE), formerly known as subclinical hepatic encephalopathy, is the mild cognitive impairment commonly seen in patients who have cirrhosis. Current understanding suggests that MHE forms part of the spectrum of hepatic encephalopathy, although this remains to be proven. Although traditionally viewed as having negligible clinical significance, MHE has a significant impact on quality of life. MHE often goes undiagnosed because in many patients there is no evidence of clinically overt signs of impaired cognition. In addition, the diagnostic criteria for MHE have not been standardized, which means that the exact characteristics of MHE remain in question. This Review focuses on the pathogenesis and neuropsychological findings (incorporating neuroimaging) of MHE, as well as the effect of MHE on quality of life and survival, and developments in treatment.

UR - http://www.scopus.com/inward/record.url?scp=36649018910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36649018910&partnerID=8YFLogxK

U2 - 10.1038/ncpgasthep0999

DO - 10.1038/ncpgasthep0999

M3 - Article

VL - 4

SP - 677

EP - 685

JO - Nature Reviews Gastroenterology and Hepatology

JF - Nature Reviews Gastroenterology and Hepatology

SN - 1759-5045

IS - 12

ER -